Medasense Biometrics
Tel Aviv, Israel· Est.
AI‑powered pain quantification platform that personalizes analgesia and cuts healthcare costs.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered pain quantification platform that personalizes analgesia and cuts healthcare costs.
Pain ManagementAnesthesiaCritical Care
Technology Platform
NOL® (Nociception Level) AI‑driven sensor platform that continuously quantifies pain by integrating multimodal physiological signals into a real‑time pain score.
Opportunities
Expansion into chronic‑pain clinics, integration with hospital EMR and analytics platforms, and leveraging real‑world evidence for value‑based reimbursement.
Risk Factors
Regulatory clearance for new indications, adoption hurdles in traditional surgical workflows, and competition from alternative pain‑monitoring technologies.
Competitive Landscape
Few competitors offer continuous, AI‑based pain quantification; Medasense differentiates through validated NOL algorithms, FDA clearance, and strong partnerships with major device distributors.